Key statistics dashboard for Oramed Pharmaceuticals Inc. (ORMP). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes.
Stock Data
| Price | $4.62 |
| Market Cap | $189M |
| Enterprise Value | $174.6M |
| Beta | 1.25 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 1.09 |
| Price / Book | 0.60 |
| P/S | 0.00 |
| EV/EBITDA | 1.15 |
| EV/Sales | 0.00 |
| EV/FCF | -32.49 |
| P/FCF | -35.19 |
| Earnings Yield | 92.23% |
| FCF Yield | -2.84% |
| Dividend Yield | 5.41% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 72.96% |
| Return on Assets | 47.31% |
| Return on Invested Capital | -3.21% |
| Return on Capital Employed | -4.05% |
Financial Health
| Current Ratio | 4.98 |
| Quick Ratio | 4.98 |
| Cash Ratio | 1.42 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.20% |
| Net Debt / EBITDA | -0.10 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 1.91 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 7.74 |
| Cash per share | 1.23 |
| FCF per share | -0.13 |
| Tangible Book Value per share | 7.74 |
| Dividend per share | 0.25 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 6 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 8 |
| Avg rating (1-5) | 0.75 |
Related companies: CLNN · CNTB · CNTX · COYA · IFRX · IMA · KLRS
Explore sector: Healthcare · Biotechnology
More sections of ORMP: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks